Outbreak of pertussis among healthcare workers in a hospital surgical unit

Infection Control and Hospital Epidemiology

Volumn 27, Issue 6, 2006, Pages 546-552

  Pascual, F Brian ^a,b   McCall, Candace L ^b,d   McMurtray, Aaron ^b,e   Payton, Tony ^c   Smith, Forrest ^c   Bisgard, Kristine M ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c OHIO DEPARTMENT OF HEALTH   (United States)

^d Air Force Materiel Command   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; BORDETELLA PERTUSSIS; CELL CULTURE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; COUGHING; DISEASE CONTROL; EPIDEMIC; HEALTH CARE PERSONNEL; HOSPITAL SUBDIVISIONS AND COMPONENTS; HUMAN; HUMAN CELL; INTERVIEW; LABORATORY TEST; MASK; OPERATING ROOM PERSONNEL; PERTUSSIS; POLYMERASE CHAIN REACTION; PROPHYLAXIS; SEROLOGY; SYMPTOMATOLOGY;

ADULT; BORDETELLA PERTUSSIS; CROSS INFECTION; DISEASE OUTBREAKS; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; HEALTH PERSONNEL; HOSPITAL UNITS; HOSPITALS, COMMUNITY; HUMANS; INFECTION CONTROL; MALE; MASKS; UNITED STATES; WHOOPING COUGH;

EID: 33745780695     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/506232     Document Type: Article

References (38)

1. Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage levels among children aged 19-35 months-United States, 2004. MMWR Morb Mortal Wkly Rep 2005; 54:717-721.
2. Lambert HJ. Epidemiology of a small pertussis outbreak in Kent County, Michigan. Pub Hlth Rep 1965; 80:365-369.
3. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. BMJ 1988; 296:612-614.
4. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices. ACIP Votes to Recommend Use of Combined Tetanus, Diphtheria and Pertussis (Tdap) Vaccine for Adults. March 2, 2006. Atlanta, GA: CDC; 2006. Available at: http://www.cdc.gov/nip/vaccine/tdap/tdap_adult_recs. pdf. Accessed March 19, 2006.
5. Centers for Disease Control and Prevention. Summary of notifiable diseases-United States, 2003. MMWR Morb Mortal Wkly Rep 2005; 52:1-85.
6. Centers for Disease Control and Prevention. Provisional cases of selected notifiable diseases, United States, weekly report ending Dec 31, 2005, and Jan 1, 2006. MMWR Morb Mortal Wkly Rep 2006; 54:1327. Available at: http://www.cdc.gov/mmwr/PDF/wk/mm5451.pdf. Accessed May 24, 2006.
7. Güriş D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28:1230-1237.
8. Centers for Disease Control and Prevention. Pertussis-United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2005; 54:1283-1286.
9. Sutler R, Cochi S. Pertussis hospitalizations and mortality in the United States, 1985-1988: evaluation of the completeness of national reporting. JAMA 1992; 267:386-391.
10. Kurt T, Yeager A, Guenette S, Dunlop S. Spread of pertussis by hospital staff. JAMA 1972; 221:264-267.
11. Linnemann CC, Ramundo N, Perlstein PH, et al. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975; 2:540-543.
12. Bassinet L, Matrat M, Njamkepo E, Aberrante S, Housset B, Guiso N. Nosocomial pertussis outbreak among adult patients and healthcare workers. Infect Control Hosp Epidemiol 2004; 25:995-997.
13. Friedman DS, Curtis CR, Schauer SL, et al. Surveillance for transmission and antibiotic adverse events among neonates and adults exposed to a healthcare worker with pertussis. Infect Control Hosp Epidemiol 2004; 25:967-973.
14. Centers for Disease Control and Prevention. Outbreak of pertussis associated with hospitals-Pennsylvania, Kentucky, Oregon, 2003. MMWR Morb Mortal Wkly Rep 2005; 54:67-71 [published correction appears in MMWR Morb Mortal Wkly Rep 2005; 54:127].
15. Meade BD, Deforest A, Edwards KM, et al. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 1995; 96:570-575 [published correction appears in Pediatrics 1995; 96:1199].
16. Baughman AL, Bisgard KM, Edwards KM, et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 2004; 11:1045-1053.
17. SAS Institute. The FREQ procedure. In: SAS/STAT Software, Release 8.2: Changes and Enhancements. Ed. 1. Cary, NC: SAS Publishing; 2001: 17-20.
18. Cherry JD, Beer T, Chartrand SA, et al. Comparison of values of antibody to Bordetella pertussis antigens in young German and American men. Clin Infect Dis 1995; 20:1271-1274.
19. Nelson JD. The changing epidemiology of pertussis in young infants: the role of adults as reservoirs of infection. Am J Dis Child 1978; 132: 371-373.
20. Aoyama T, Takeuchi Y, Goto A, Iwai H, Murase Y, Iwata T. Pertussis in adults. Am J Dis Child 1992; 146:163-166.
21. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23:985-989.
22. Jenkins P, Clarke S. Cough syncope: a complication of adult whooping cough. Br J Dis Chest 1981; 75:311-313.
23. Lee LM, Lett S, Schauer S, et al. Societal costs and morbidity of pertussis in adolescents and adults. Clin Infect Dis 2004; 39:1572-1580.
24. Lievano FA, Reynolds MW, Waring AL, et al. Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. J Clin Microbiol 2002; 40:2801-2805.
25. Müller FM, Hoppe JE, Wirsing von König CH. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997; 35:2435-2443.
26. Yih, WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000; 182:1409-1416.
27. Onorato IM, Wassilak SG. Laboratory diagnosis of pertussis: the state of the art. Pediatr Infect Dis J 1987; 6:145-151.
28. Hallander HO, Storsaeter J, Mollby R. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. J Infect Dis 1991; 163:1046-1054.
29. Strebel PM, Cochi SL, Farizo KM, et al. Pertussis in Missouri: evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis. Clin Infect Dis 1993; 16:276-285.
30. Matlow AG, Neslon S, Wray R, Cox P. Nosocomial acquisition of pertussis diagnosed by polymerase chain reaction. Infect Control Hosp Epidemiol 1997; 18:715-716.
31. Centers for Disease Control and Prevention. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2004; 53(RR-3):1-36.
32. Herwaldt LA. Pertussis in adults: what physicians need to know. Arch Intern Med 1991; 15:1510-1512.
33. Bass JW, Klenk EL, Katheimer JB, et al. Antimicrobial treatment of pertussis. J Pediat 1969; 75:768-781.
34. Nelson JD. Antibiotic treatment of pertussis. Pediatrics 1969; 44:474-476.
35. Hewlett EL, Edwards KM. Pertussis-not just for kids. N Engl J Med 2005; 352:1215-1222.
36. Centers for Disease Control and Prevention, recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep 2005; 54(RR-14):1-16.
37. Centers for Disease Control and Prevention (CDC). Respiratory Hygiene/Cough Etiquette in Healthcare Settings. Atlanta, GA. CDC; 2004. Available at: http://www.cdc.gov/flu/professionals/pdf/resphygiene.pdf. Accessed March 19, 2006.
38. Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchman SD. Guideline for infection control in health care personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1998; 19:407-463 [published correction appears in Infect Control Hosp Epidemiol 1998; 19:493].